<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510081</url>
  </required_header>
  <id_info>
    <org_study_id>1253-013</org_study_id>
    <nct_id>NCT00510081</nct_id>
  </id_info>
  <brief_title>An Evaluation of an Injectable Material for Correction of Wrinkles</brief_title>
  <official_title>An Open Label Evaluation of the Safety and Efficacy of Calcium Hydroxylapatite (Radiesse®) Injection in the Correction of Jowl-Associated Chin Notches</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the effectiveness of a filler in improving
      wrinkles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to determine whether focal injection of calcium
      hydroxylapatite (Radiesse®), an injectable biodegradable filler, into jowl-induced chin
      notches can result in safe, aesthetically pleasing, and long-lasting correction of these.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study was not executed. No subjects were enrolled.
  </why_stopped>
  <start_date>July 2007</start_date>
  <completion_date>February 2009</completion_date>
  <primary_completion_date>February 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correction of wrinkles</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development of adverse events</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Jowls</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects will receive filler injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Calcium Hydroxylapatite injection</intervention_name>
    <description>filler injection</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Radiesse</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40-65

          -  Have wrinkles

          -  The subjects are in good health.

          -  The subject has willingness and the ability to understand and provide informed consent
             for the use of their tissue and communicate with the investigator.

        Exclusion Criteria:

          -  Subjects who have received within the past 3 months or are planning to receive in the
             next 6 months, botulinum toxin injections for correction of wrinkles.

          -  Subjects who have received within the past one year any soft tissue augmentation
             material into the chin and experimental area (defined as any area on the face below
             the lower lip vermilion, excluding the lateral lip marionette line up to 1 cm below
             this level).

          -  Subjects with prior history of nodule formation or hypersensitivity reactions to
             lidocaine or medium-term augmentation materials, including hyaluronic acid
             derivatives, poly-L-lactic acid, and calcium hydroxylapatite.

          -  Subjects who are currently using anticoagulation therapy.

          -  Subjects who have a history of bleeding disorders.

          -  Subjects who are unable to understand the protocol or to give informed consent.

          -  Subjects with mental illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murad Alam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University, Feinberg School of Medicine, Department of Dermatology</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2007</study_first_submitted>
  <study_first_submitted_qc>July 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2007</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2014</last_update_posted>
  <responsible_party>
    <name_title>Murad Alam, MD</name_title>
    <organization>Northwestern University</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

